Cascadian Therapeutics (Formally known as Oncothyreon)
2601 Fourth Avenue
Suite 500
Seattle
Washington
98121
United States
Tel: 206-801-2100
Fax: 206-801-2101
Website: http://www.cascadianrx.com/
233 articles about Cascadian Therapeutics (Formally known as Oncothyreon)
-
Oncothyreon Inc. Announces Full Year And Fourth Quarter 2014 Financial Results Conference Call
3/3/2015
-
Oncothyreon Inc. Announces Appointment Of Steven P. James To Board Of Directors
3/3/2015
-
Oncothyreon Inc. To Present At Upcoming Investor Conferences
2/17/2015
-
Oncothyreon Inc. Prices $22 Million Concurrent Public Offerings Of Common Stock And Preferred Stock
2/6/2015
-
Oncothyreon Inc. Announces Proposed Public Offerings
2/6/2015
-
Adimab LLC. Announces New Partnerships With Acceleron Pharma, Oncothyreon Inc., Surface Oncology And Potenza
1/9/2015
-
Oncothyreon Inc. Strikes $300 Million Cancer Pact With Array BioPharma, Inc.
12/15/2014
-
Oncothyreon Inc. Announces Presentation Of Positive ONT-380 Data At San Antonio Breast Cancer Symposium
12/12/2014
-
Oncothyreon Inc. To Present At Stifel 2014 Healthcare Conference
11/12/2014
-
Oncothyreon Inc. And Celldex Therapeutics, Inc. Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab
11/11/2014
-
Oncothyreon Inc. Reports Third Quarter 2014 Financial Results
11/7/2014
-
Oncothyreon Inc. Announces Third Quarter 2014 Financial Results Conference Call
10/30/2014
-
Oncothyreon Inc. Prices $40 Million Concurrent Public Offerings Of Common Stock And Preferred Stock
9/18/2014
-
Oncothyreon Inc. Announces Proposed Public Offerings
9/18/2014
-
Oncothyreon Inc. To Present At Rodman & Renshaw Global Investment Conference
9/3/2014
-
Oncothyreon Inc.'s Lung Cancer Drug EMR 63325-009 Misses Primary Endpoint In Phase 1 Study
8/20/2014
-
Oncothyreon Inc. Reports Second Quarter 2014 Financial Results
8/12/2014
-
Oncothyreon Inc. Announces Acquisition Of Alpine Biosciences
8/12/2014
-
Oncothyreon Inc. Announces Second Quarter 2014 Financial Results Conference Call
8/4/2014
-
Oncothyreon Inc. Announces Presentation Of ONT-10 Data At American Society of Clinical Oncology Annual Meeting
6/2/2014